Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Methicillin-resistant Staphylococcus aureus--an overview.

H J Eadon1, R J Pinney

  • 1Department of Pharmaceutics, School of Pharmacy, University of London, U.K.

Journal of Clinical Pharmacy and Therapeutics
|December 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Investigation of Smith's quinolone killing mechanisms during the PAE of ciprofloxacin on Escherichia coli.

International journal of pharmaceutics·2001
Same author

Flow cytometric investigation of filamentation, membrane patency, and membrane potential in Escherichia coli following ciprofloxacin exposure.

Antimicrobial agents and chemotherapy·2000
Same author

Susceptibilities of Actinobacillus actinomycetemcomitans biofilms to oral antiseptics.

Journal of medical microbiology·1997
Same author

Post-UV survival of Escherichia coli strains carrying more than one UV-sensitising plasmid.

Mutation research·1996
Same author

Positive R plasmid mutator effect on chromosomal mutation to nalidixic acid resistance in nalidixic acid-exposed cultures of Escherichia coli.

The Journal of antimicrobial chemotherapy·1995
Same author

Epidemiology and susceptibilities to mercury preservatives of staphylococci isolated from used eye-drops preserved with thiomersal.

The Journal of pharmacy and pharmacology·1995
Same journal

Impact of pharmacist-initiated educational interventions on improving medication reconciliation practice in geriatric inpatients during hospital admission in Vietnam.

Journal of clinical pharmacy and therapeutics·2022
Same journal

Evaluation of off-label anti-vascular endothelial growth factor and steroid implant medication uses in macular edema due to retinal vein occlusion in Turkey.

Journal of clinical pharmacy and therapeutics·2022
Same journal

A descriptive analysis of pharmacological management of aggression and/or agitation in patients with traumatic brain injury in a Southwest Virginia inpatient population.

Journal of clinical pharmacy and therapeutics·2022
Same journal

Effects of caregiver counselling on medication persistence and adherence in patients with dementia at a pharmacist-managed clinic: A pilot study.

Journal of clinical pharmacy and therapeutics·2022
Same journal

The 50% and 95% effective doses of remimazolam tosilate with adjuvant sufentanil for sedation in patients with liver cirrhosis undergoing oesophagogastric varices screening endoscopy.

Journal of clinical pharmacy and therapeutics·2022
Same journal

Tumour necrosis factor inhibitor combined with intravenous immunoglobulin and heparin for treatment of recurrent spontaneous abortion: A two-centre, retrospective, cohort study.

Journal of clinical pharmacy and therapeutics·2022
See all related articles

Methicillin-resistant Staphylococcus aureus (MRSA) infections are dangerous due to identification challenges, not increased pathogenicity. New detection methods and treatments offer hope for better hospital infection control.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Clinical Medicine

Background:

  • Methicillin-resistant Staphylococcus aureus (MRSA) causes severe infections.
  • MRSA is not inherently more pathogenic than methicillin-sensitive strains.
  • Misidentification of MRSA leads to ineffective treatment and poor patient outcomes.

Purpose of the Study:

  • To highlight the challenges in identifying and treating MRSA infections.
  • To discuss the limited therapeutic options for MRSA.
  • To review the development of new detection methods and anti-MRSA agents.

Main Methods:

  • Review of current literature on MRSA.
  • Analysis of diagnostic challenges.
  • Evaluation of emerging therapeutic strategies.

Related Experiment Videos

Main Results:

  • MRSA infections pose a significant threat primarily due to diagnostic difficulties and limited treatment options.
  • Despite increasing resistance, new detection and treatment methods are under development.
  • Control measures are essential for containing MRSA spread.

Conclusions:

  • The primary issue with MRSA lies in its accurate and timely identification.
  • Ongoing development of novel anti-MRSA agents is crucial for managing hospital-acquired infections.
  • The future outlook for controlling MRSA in healthcare settings is cautiously optimistic with continued innovation.